Skip to main content
· 3/21/2000

Hollander v. Sandoz Pharmaceuticals Corp.

Citations

  • 95 F. Supp. 2d 1230
  • 2000 U.S. Dist. LEXIS 8776
  • 2000 WL 430174

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • excluding Dr. Kulig’s testimony and stating that he “could only list ‘possible’ mechanisms for Parlodel® causing hypertension”
  • rejecting Dr. Kulig’s reliance on case reports because, inter alia, these reports “fail to take into account the postpartum incidence of stroke and other factors”
  • no reliable evidence that “bromocriptine and the other Ergots have sufficiently similar physiological effects to warrant comparison”
  • “The plaintiffs have failed to demonstrate that bromocriptine and the other ergots have sufficiently similar physiological effects to warrant comparison.”
  • “The plaintiffs have failed to demonstrate that bromocriptine and the other ergots have sufficiently similar physiological effects to warrant comparison.”
  • rejecting Dr. Kulig’s reliance on other ergots evidence

Source: CourtListener parenthetical corpus (CC0).

Judges: Ralph G. Thompson

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.